Skip to main content
. 2020 Jun;48(6):438–445. doi: 10.1124/dmd.119.090407

Fig. 3.

Fig. 3.

Metabolism of RS-bupropion catalyzed by coexpressed recombinant CYP2B6.1/POR variants/b5 at concentration of 2 µM RS-bupropion (1 µM R- or S-bupropion). Results are the mean ± 95% confidence interval of triplicate determinations. Asterisks denote rates significantly different from the wild-type POR (P < 0.001 for R-bupropion and P = 0.002 for S-bupropion). (A) R,R-hydroxybupropion formation from RS-bupropion. (B) S,S-hydroxybupropion formation from RS-bupropion.